MyFinsight

HomeBlogAboutContact

MyFinsight

Making company financials insightful for everyone

Quick Links

  • About
  • Blog
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

For the quarter ending 2026-03-31, AXSM has $713,607K in assets. $659,020K in debts. $305,106K in cash and cash equivalents.

Balance Sheets Overview

Current Ratio
139.16%
Quick Ratio
131.98%
Cash Ratio
69.47%
Debt to Asset Ratio
92.35%
Unit: Thousand (K) dollars
Assets Breakdown
    • Cash and cash equivalents
    • Inventories, net
    • Non-current inventory and other ...
    • Others
Liabilities Breakdown
    • Additional paid-in capital
    • Accumulated deficit
    • Loan payable, long-term
    • Others

Balance Sheets
2026-03-31
2025-12-31
2025-09-30
2025-06-30
Cash and cash equivalents
305,106 322,933 325,272 303,016
Accounts receivable, net
251,062 224,464 196,507 198,825
Inventories, net
31,515 27,938 23,774 18,441
Prepaid and other current assets
23,523 13,651 19,789 16,338
Total current assets
611,206 588,986 565,342 536,620
Equipment, net
567 562 605 667
Right-of-use asset - operating lease
20,014 20,858 21,654 22,472
Goodwill
12,042 12,042 12,042 12,042
Intangible asset, net
38,947 40,519 42,126 43,733
Non-current inventory and other assets
30,831 26,838 27,481 24,251
Total assets
713,607 689,805 669,250 639,785
Accounts payable
106,702 65,537 54,227 91,628
Accrued expenses and other current liabilities
250,731 232,853 225,632 170,902
Operating lease liability, current portion
628 434 736 337
Contingent consideration, current
11,150 10,012 9,695 9,232
Short-term borrowings
70,000 70,000 70,000 70,000
Total current liabilities
439,211 378,836 360,290 342,099
Contingent consideration, non-current
73,730 77,540 89,870 79,655
Loan payable, long-term
117,850 117,746 117,642 117,540
Operating lease liability, long-term
22,385 23,182 23,041 23,624
Finance lease liability, long-term
5,844 4,206 4,680 3,792
Total liabilities
659,020 601,510 595,523 566,710
Common stock, 0.0001 par value per share (150,000,000 shares authorized, and 50,882,766 shares issued and outstanding at march 31,2026 and december 31, 2025, respectively)
5 5 5 5
Additional paid-in capital
1,425,085 1,394,251 1,351,124 1,303,243
Accumulated deficit
-1,370,503 -1,305,961 -1,277,402 -1,230,173
Total stockholders equity
54,587 88,295 73,727 73,075
Total liabilities and stockholders equity
713,607 689,805 669,250 639,785
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.

Time Plot

Show the time plot by selecting a row from the table.

Balance Sheets

Cash and cashequivalents$305,106K Accounts receivable, net$251,062K Inventories, net$31,515K Prepaid and othercurrent assets$23,523K Total current assets$611,206K Intangible asset, net$38,947K Non-current inventory andother assets$30,831K Right-of-use asset -operating lease$20,014K Goodwill$12,042K Equipment, net$567K Total assets$713,607K Total liabilities andstockholders equity$713,607K Total liabilities$659,020K Total stockholdersequity$54,587K Accumulated deficit-$1,370,503K Total currentliabilities$439,211K Loan payable,long-term$117,850K Contingent consideration,non-current$73,730K Operating leaseliability, long-term$22,385K Finance leaseliability, long-term$5,844K Additional paid-in capital$1,425,085K Common stock, 0.0001par value per share...$5K Accrued expenses andother current...$250,731K Accounts payable$106,702K Short-term borrowings$70,000K Contingent consideration,current$11,150K Operating leaseliability, current portion$628K

Axsome Therapeutics, Inc. (AXSM)

Axsome Therapeutics, Inc. (AXSM)